Acadia Pharmaceuticals | ACAD - Le Revenu D'Intérêts

Prix De L'Action
21.96
Variation Quotidienne
-0.15 -0.68%
Mensuellement
-0.23%
Annuel
49.08%
Q2 Prévisions
21.49




Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
ALKERMES USD 11.94M 853K 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Cara Therapeutics USD 347K 74K 2025-03
Corcept Therapeutics USD 5.02M 7K 2025-09
Cytokinetics USD 10.25M 2.75M 2025-09
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Incyte USD 30.75M 3.97M 2025-12
J&J USD 2.14 237M 2026-03
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Prothena USD 3.35M 443K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09